Michael Retsky, principal of ELOPT, received a PhD in physics
from University of Chicago in 1974. In addition to his physics activities, he also had a part time appointment for 12 years
as Lecturer in Surgery in the late Judah Folkman's Vascular Biology Department at Harvard Medical School and currently
is part time Research Associate at Harvard School of Public Health.
A particular interest in medical research is the impact of surgery
on tumor dormancy in breast cancer. Links and recent papers are contained in cancer research pages. This project
benefited initially from a Phase I SBIR grant from NIH to make an expert system for breast cancer. It is now supported by
a $600k 3-year grant from Komen Foundation.
Michael and collaborators have had a number of invited reviews on breast
cancer including a paper in Nature - Clinical Practice of Oncology. This research has resulted in several press releases
from Harvard Medical School and has been discussed in Wall Street Journal, Boston Globe, Baltimore Sun, and a number of popular
websites. ELOPT has benefited from five grants including a phase I SBIR from NIH (different from the ones
mentioned above).
